Article thumbnail

MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments

By Stewart J. Tepper, Shashidhar H. Kori, Peter J. Goadsby, Paul K. Winner, Min H. Wang, Stephen D. Silberstein and F. Michael Cutrer

Abstract

OBJECTIVE: To evaluate the efficacy of MAP0004, an orally inhaled dihydroergotamine, for acute treatment of migraine when administered at various time points from within 1 hour to more than 8 hours after migraine onset

Topics: Original Articles
Publisher: Mayo Foundation for Medical Education and Research
OAI identifier: oai:pubmedcentral.nih.gov:3184024
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles